2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune DiseasesFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Multi-Drug Resistant Nephrotic Syndrome, Skin and Connective Tissue Diseases, Urogenital Diseases, autoimmune disease, connective tissue disorder, glomerulonephritis, immune system disorder, kidney disorder, nephritis, nephrosis, nephrotic syndrome, systemic lupus erythematosus, urinary system disorderNot yet recruitingEarly phase 12026-06-29NCT07674147
Chimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory NeuroblastomaDisease Attributes, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, epithelial neoplasm, neoplasm, neuroblastoma, neuroepithelial neoplasm, primitive neuroectodermal tumorRecruitingPhase 12025-02-07NCT06751134